Advertisement
What will happen with healthcare policy under President Trump ... or ... Clinton

What will happen with healthcare policy under President Trump ... or ... Clinton

By Harris Meyer  |  July 23, 2016

The November elections surely won't end the nonstop, eight-year political war over the shape of the U.S. healthcare system. But the ballot results likely will determine whether the changes driven by the ACA continue in the same direction or the system returns to its previous, less-regulated form.

Decisio Health delivers data bedside in the ICU

Decisio Health delivers data bedside in the ICU

By Erica Teichert  |  July 23, 2016

Houston-based Decisio Health developed the first FDA-approved web-based clinical platform and created easy-to-read displays that alert clinicians to problems as they emerge.

Long-term costs of Zika among the many unknowns of the virus

Long-term costs of Zika among the many unknowns of the virus

By Shannon Muchmore  |  July 23, 2016

History buffs and infectious-disease experts have already drawn links between the rubella outbreak in the 1960s and the current spread of Zika. But drugmakers today face greater regulatory hurdles, and the federal government has yet to dedicate funding to address the Zika epidemic.

Supply chain firms to discuss effects of UDI mandate

By Adam Rubenfire  |  July 23, 2016

A federal mandate to use unique device identifiers offers an opportunity to reduce the risk of patients being harmed by products, but the UDI system, which is being implemented over the next four years by the Food and Drug Administration, means a lot of changes— especially for the...

Abbott gains approval for first fully dissolving artery stent

Abbott gains approval for first fully dissolving artery stent

By Adam Rubenfire  |  July 05, 2016

The Food and Drug Administration has approved the first fully absorbable stent used to treat coronary artery disease. But physicians are likely to keep using metallic stents until later generations of biodegradable stents are released and more data are gathered on trial patients.

FDA approves first pill to treat all forms of hepatitis C

By Associated Press  |  June 28, 2016

Federal health officials have approved the first pill to treat all major forms of hepatitis C, the latest in a series of drug approvals that have reshaped treatment of the liver-destroying virus.

Drug companies fight generics with coupons

Drug companies fight generics with coupons

By Howard Wolinsky  |  June 11, 2016

Drugmakers are making increased use of consumer coupons, which are designed to thwart the high copays used by pharmacy benefit managers and insurers to channel consumers to less-costly generic drugs.

McKesson Corp. weighs separation from its IT unit

By Modern Healthcare  |  June 04, 2016

McKesson Corp. may be weighing a separation of its information technology unit as it works to contain costs and refocus on its core drug distribution business, according to the Wall Street Journal.

Advertisement
Modern Healthcare Daily

Award winning coverage of healthcare business and policy news.

The Modern Healthcare app includes a personalized home screen, strong search functionality and immediate downloads from the industry's leading healthcare media brand.